DUBLIN, August 12, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Testosterone Replacement Therapy Market 2016-2020" report to their offering.
The report forecasts the global testosterone replacement therapy market is gradually declining and will post a CAGR of (3.35) % during the period 2016-2020.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
According to the report, increase in older population will be a key driver for market growth. Age related lowering of testosterone presents features both primary and secondary hypogonadism. Improved healthcare infrastructure and sophisticated treatment facilities have increased life expectancy of individuals. This has led to an increase in older adult population worldwide.
Further, the report states that generic erosion will be a challenge for the market. The entry of generic drugs in the market results in the decline in the overall market revenue, thus affecting the growth of the market. Though all marketed drugs have not lost their respective patents, generic testosterone formulations are available in the market. The branded versions of the drug costs around $300 - $350 per month and generic versions of testosterone shots can be obtained at as low as $20 per dose. Thus, the generic erosion of drugs acts as a challenge for the growth of the market.
- Eli Lilly and Company
- Endo Pharmaceuticals
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Hypogonadism
PART 06: Pipeline analysis
PART 07: Key buying criteria
PART 08: Market landscape
PART 09: Market segmentation by dosage form
PART 10: Geographical segmentation
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
PART 17: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/tpn38c/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-testosterone-replacement-therapy-market-to-grow-335-by-2020----fda-warnings-on-use-of-testosterone-products-a-key-challenge---research-and-markets-300312964.html
SOURCE Research and Markets